14 pages, 237 KiB  
Review
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis
by Silvia Cantara *, Carlotta Marzocchi, Tania Pilli, Sandro Cardinale, Raffaella Forleo, Maria Grazia Castagna and Furio Pacini
Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy
Int. J. Mol. Sci. 2017, 18(4), 775; https://doi.org/10.3390/ijms18040775 - 6 Apr 2017
Cited by 20 | Viewed by 8080
Abstract
Fine needle aspiration cytology (FNAC) represents the gold standard for determining the nature of thyroid nodules. It is a reliable method with good sensitivity and specificity. However, indeterminate lesions remain a diagnostic challenge and researchers have contributed molecular markers to search for in [...] Read more.
Fine needle aspiration cytology (FNAC) represents the gold standard for determining the nature of thyroid nodules. It is a reliable method with good sensitivity and specificity. However, indeterminate lesions remain a diagnostic challenge and researchers have contributed molecular markers to search for in cytological material to refine FNAC diagnosis and avoid unnecessary surgeries. Nowadays, several “home-made” methods as well as commercial tests are available to investigate the molecular signature of an aspirate. Moreover, other markers (i.e., microRNA, and circulating tumor cells) have been proposed to discriminate benign from malignant thyroid lesions. Here, we review the literature and provide data from our laboratory on mutational analysis of FNAC material and circulating microRNA expression obtained in the last 6 years. Full article
(This article belongs to the Special Issue Current Knowledge in Thyroid Cancer—From Bench to Bedside)
Show Figures

Graphical abstract

13 pages, 4172 KiB  
Article
SCF/C-Kit/JNK/AP-1 Signaling Pathway Promotes Claudin-3 Expression in Colonic Epithelium and Colorectal Carcinoma
by Yaxi Wang 1,2, Tingyi Sun 1,2,3, Haimei Sun 1,2,3, Shu Yang 1,2,3, Dandan Li 1,2 and Deshan Zhou 1,2,3,*
1 Department of Histology and Embryology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China
2 Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Beijing 100069, China
3 Cancer Institute of Capital Medical University, Beijing 100069, China
Int. J. Mol. Sci. 2017, 18(4), 765; https://doi.org/10.3390/ijms18040765 - 6 Apr 2017
Cited by 27 | Viewed by 7280
Abstract
Claudin-3 is a major protein of tight junctions (TJs) in the intestinal epithelium and is critical for maintaining cell-cell adhesion, barrier function, and epithelium polarity. Recent studies have shown high claudin-3 levels in several solid tumors, but the regulation mechanism of claudin-3 expression [...] Read more.
Claudin-3 is a major protein of tight junctions (TJs) in the intestinal epithelium and is critical for maintaining cell-cell adhesion, barrier function, and epithelium polarity. Recent studies have shown high claudin-3 levels in several solid tumors, but the regulation mechanism of claudin-3 expression remains poorly understood. In the present study, colorectal cancer (CRC) tissues, HT-29 and DLD-1 CRC cell lines, CRC murine model (C57BL/6 mice) and c-kit loss-of-function mutant mice were used. We demonstrated that elevated claudin-3 levels were positively correlated with highly expressed c-kit in CRC tissues based upon analysis of protein expression. In vitro, claudin-3 expression was clearly increased in CRC cells by overexpressed c-kit or stimulated by exogenous recombinant human stem cell factor (rhSCF), while significantly decreased by the treatment with c-kit or c-Jun N-terminal kinase (JNK) inhibitors. Chromatin immunoprecipitation (ChIP) and luciferase reporter assay showed that SCF/c-kit signaling significantly promoted activator protein-1 (AP-1) binding with CLDN-3 promoter and enhanced its transcription activity. Furthermore, decreased expression of claudin-3 was obtained in the colonic epithelium from the c-Kit loss-of-function mutant mice. In conclusion, SCF/c-kit-JNK/AP-1 signaling pathway significantly promoted claudin-3 expression in colonic epithelium and CRC, which could contribute to epithelial barrier function maintenance and to CRC development. Full article
(This article belongs to the Special Issue Kinase Signal Transduction 2017)
Show Figures

Figure 1

15 pages, 4587 KiB  
Article
Enumeration and Localization of Mesenchymal Progenitor Cells and Macrophages in Synovium from Normal Individuals and Patients with Pre-Osteoarthritis or Clinically Diagnosed Osteoarthritis
by Kate O’Brien 1, Pankaj Tailor 1,2, Catherine Leonard 1, Lisa M. DiFrancesco 3, David A. Hart 1,4, John R. Matyas 1,5, Cyril B. Frank 1,4 and Roman J. Krawetz 1,2,4,6,*
1 McCaig Institute for Bone & Joint Health, University of Calgary, Calgary, AB T2N4N1, Canada
2 Department Cell Biology and Anatomy, University of Calgary, Calgary, AB T2N4N1, Canada
3 Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, AB T2N4N1, Canada
4 Department of Surgery, University of Calgary, Calgary, AB T2N4N1, Canada
5 Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB T2N4N1, Canada
6 The D-BOARD European Consortium for Biomarker Discovery, School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK
Int. J. Mol. Sci. 2017, 18(4), 774; https://doi.org/10.3390/ijms18040774 - 5 Apr 2017
Cited by 40 | Viewed by 5149
Abstract
Osteoarthritis (OA) is a degenerative disorder characterized by chondrocyte apoptosis and degeneration of articular cartilage resulting in loss of mobility and pain. Inflammation plays a key role in the development and progression of OA both on the side of apoptosis and repair, while [...] Read more.
Osteoarthritis (OA) is a degenerative disorder characterized by chondrocyte apoptosis and degeneration of articular cartilage resulting in loss of mobility and pain. Inflammation plays a key role in the development and progression of OA both on the side of apoptosis and repair, while its exact role in pathogenesis has yet to be fully elucidated. Few studies have examined the cellular composition (inflammatory cells and/or progenitor cells) in the synovium of patients with pre-OA (asymptomatic with cartilage damage). Therefore, in the current study, mesenchymal progenitor cells (MPCs) and macrophages were enumerated within normal, pre-OA and OA synovium. No differences were observed between MPCs in normal vs. pre-OA, however, fewer macrophages were observed in pre-OA vs. normal synovium. Osteoarthritic synovium contained greater numbers of both MPCs and macrophages. Interestingly, the localization of MPCs and macrophages was affected by disease severity. In normal and pre-OA synovium, MPCs and macrophages co-localized, while in OA synovium, MPCs and macrophage populations were spatially distinct. Examining the cellular interactions between MPCs and macrophages in synovium may be essential for understanding the role of these cells in the onset and/or pathogenesis of the disease. This study has provided a first step by examining these cell types both spatially and temporally (e.g., disease severity). Further cellular and molecular studies will be needed to determine the functions of these cells in the context of disease and in relation to each other and the joint as a whole. Full article
(This article belongs to the Section Biochemistry)
Show Figures

Figure 1

17 pages, 5409 KiB  
Review
From Lipid Homeostasis to Differentiation: Old and New Functions of the Zinc Cluster Proteins Ecm22, Upc2, Sut1 and Sut2
by Ifeoluwapo Matthew Joshua and Thomas Höfken *
Division of Biosciences, Brunel University London, Uxbridge UB8 3PH, UK
Int. J. Mol. Sci. 2017, 18(4), 772; https://doi.org/10.3390/ijms18040772 - 5 Apr 2017
Cited by 29 | Viewed by 7380
Abstract
Zinc cluster proteins are a large family of transcriptional regulators with a wide range of biological functions. The zinc cluster proteins Ecm22, Upc2, Sut1 and Sut2 have initially been identified as regulators of sterol import in the budding yeast Saccharomyces cerevisiae. These [...] Read more.
Zinc cluster proteins are a large family of transcriptional regulators with a wide range of biological functions. The zinc cluster proteins Ecm22, Upc2, Sut1 and Sut2 have initially been identified as regulators of sterol import in the budding yeast Saccharomyces cerevisiae. These proteins also control adaptations to anaerobic growth, sterol biosynthesis as well as filamentation and mating. Orthologs of these zinc cluster proteins have been identified in several species of Candida. Upc2 plays a critical role in antifungal resistance in these important human fungal pathogens. Upc2 is therefore an interesting potential target for novel antifungals. In this review we discuss the functions, mode of actions and regulation of Ecm22, Upc2, Sut1 and Sut2 in budding yeast and Candida. Full article
(This article belongs to the Special Issue Metalloproteins 2017)
Show Figures

Figure 1

19 pages, 1097 KiB  
Review
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Nexus Implicated in Bowel Disease Pathophysiology
by Wai Chin Chong, Madhur D. Shastri * and Rajaraman Eri *
School of Health Science, University of Tasmania, Newnham TAS 7248, Australia
Int. J. Mol. Sci. 2017, 18(4), 771; https://doi.org/10.3390/ijms18040771 - 5 Apr 2017
Cited by 256 | Viewed by 12186
Abstract
The endoplasmic reticulum (ER) is a complex protein folding and trafficking organelle. Alteration and discrepancy in the endoplasmic reticulum environment can affect the protein folding process and hence, can result in the production of misfolded proteins. The accumulation of misfolded proteins causes cellular [...] Read more.
The endoplasmic reticulum (ER) is a complex protein folding and trafficking organelle. Alteration and discrepancy in the endoplasmic reticulum environment can affect the protein folding process and hence, can result in the production of misfolded proteins. The accumulation of misfolded proteins causes cellular damage and elicits endoplasmic reticulum stress. Under such stress conditions, cells exhibit reduced functional synthesis, and will undergo apoptosis if the stress is prolonged. To resolve the ER stress, cells trigger an intrinsic mechanism called an unfolded protein response (UPR). UPR is an adaptive signaling process that triggers multiple pathways through the endoplasmic reticulum transmembrane transducers, to reduce and remove misfolded proteins and improve the protein folding mechanism, in order to improve and maintain endoplasmic reticulum homeostasis. An increasing number of studies support the view that oxidative stress has a strong connection with ER stress. During the protein folding process, reactive oxygen species are produced as by-products, leading to impaired reduction-oxidation (redox) balance conferring oxidative stress. As the protein folding process is dependent on redox homeostasis, the oxidative stress can disrupt the protein folding mechanism and enhance the production of misfolded proteins, causing further ER stress. It is proposed that endoplasmic reticulum stress and oxidative stress together play significant roles in the pathophysiology of bowel diseases. Full article
(This article belongs to the Special Issue Modulators of Endoplasmic Reticulum Stress 2016)
Show Figures

Figure 1

13 pages, 1233 KiB  
Case Report
Rapid Identification of Pathogenic Variants in Two Cases of Charcot-Marie-Tooth Disease by Gene-Panel Sequencing
by Chi-Chun Ho 1,†, Shuk-Mui Tai 2,†, Edmond Chi-Nam Lee 3, Timothy Shin-Heng Mak 4, Timothy Kam-Tim Liu 2, Victor Wai-Lun Tang 1 and Wing-Tat Poon 1,*
1 Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China
2 Department of Paediatrics & Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China
3 Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, China
4 Centre for Genomic Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China
These authors contributed equally to this work.
Int. J. Mol. Sci. 2017, 18(4), 770; https://doi.org/10.3390/ijms18040770 - 5 Apr 2017
Cited by 12 | Viewed by 4684
Abstract
Charcot-Marie-Tooth disease (CMT) is a common inherited peripheral neuropathy affecting up to 1 in 1214 of the general population with more than 60 nuclear genes implicated in its pathogenesis. Traditional molecular diagnostic pathways based on relative prevalence and clinical phenotyping are limited by [...] Read more.
Charcot-Marie-Tooth disease (CMT) is a common inherited peripheral neuropathy affecting up to 1 in 1214 of the general population with more than 60 nuclear genes implicated in its pathogenesis. Traditional molecular diagnostic pathways based on relative prevalence and clinical phenotyping are limited by long turnaround time, population-specific prevalence of causative variants and inability to assess multiple co-existing variants. In this study, a CMT gene panel comprising 27 genes was used to uncover the pathogenic mutations in two index patients. The first patient is a 15-year-old boy, born of consanguineous parents, who has had frequent trips and falls since infancy, and was later found to have inverted champagne bottle appearance of bilateral legs and foot drop. His elder sister is similarly affected. The second patient is a 37-year-old woman referred for pre-pregnancy genetic diagnosis. During early adulthood, she developed progressive lower limb weakness, difficulties in tip-toe walking and thinning of calf muscles. Both patients are clinically compatible with CMT, have undergone multiple genetic testings and have not previously received a definitive genetic diagnosis. Patients 1 and 2 were found to have pathogenic homozygous HSPB1:NM_001540:c.250G>A (p.G84R) variant and heterozygous GDAP1:NM_018972:c.358C>T (p.R120W) variant, respectively. Advantages and limitations of the current approach are discussed. Full article
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Show Figures

Figure 1

25 pages, 3471 KiB  
Review
Old Maids: Aging and Its Impact on Microglia Function
by Edward C. Koellhoffer 1, Louise D. McCullough 1,* and Rodney M. Ritzel 2
1 McGovern Medical School at UTHealth Houston, Houston, TX 77030, USA
2 Center for Shock, Trauma and Anesthesiology Research (STAR) and Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Int. J. Mol. Sci. 2017, 18(4), 769; https://doi.org/10.3390/ijms18040769 - 5 Apr 2017
Cited by 176 | Viewed by 13553
Abstract
Microglia are highly active and vigilant housekeepers of the central nervous system that function to promote neuronal growth and activity. With advanced age, however, dysregulated inflammatory signaling and defects in phagocytosis impede their ability to perform the most essential of homeostatic functions, including [...] Read more.
Microglia are highly active and vigilant housekeepers of the central nervous system that function to promote neuronal growth and activity. With advanced age, however, dysregulated inflammatory signaling and defects in phagocytosis impede their ability to perform the most essential of homeostatic functions, including immune surveillance and debris clearance. Microglial activation is one of the hallmarks of the aging brain and coincides with age-related neurodegeneration and cognitive decline. Age-associated microglial dysfunction leads to cellular senescence and can profoundly alter the response to sterile injuries and immune diseases, often resulting in maladaptive responses, chronic inflammation, and worsened outcomes after injury. Our knowledge of microglia aging and the factors that regulate age-related microglial dysfunction remain limited, as the majority of pre-clinical studies are performed in young animals, and human brain samples are difficult to obtain quickly post-mortem or in large numbers. This review outlines the impact of normal aging on microglial function, highlights the potential mechanisms underlying age-related changes in microglia, and discusses how aging can shape the recovery process following injury. Full article
(This article belongs to the Special Issue Microglia in Aging and Neurodegenerative Disease)
Show Figures

Graphical abstract

16 pages, 1981 KiB  
Article
Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging
by Rareş-Petru Moldovan 1, Sylvia Els-Heindl 2, Dennis J. Worm 2, Torsten Kniess 1, Michael Kluge 3, Annette G. Beck-Sickinger 2, Winnie Deuther-Conrad 1, Ute Krügel 4,† and Peter Brust 1,*,†
1 Helmholtz-Zentrum Dresden-Rossendorf e. V., Institute of Radiopharmaceutical Cancer Research, 04318 Leipzig, Germany
2 Institute of Biochemistry, Universität Leipzig, 04103 Leipzig, Germany
3 Department of Psychiatry, Universität Leipzig, 04103 Leipzig, Germany
4 Rudolf Boehm Institute of Pharmacology and Toxicology, Medical Faculty, Universität Leipzig, 04107 Leipzig, Germany
These authors contributed equally to this work.
Int. J. Mol. Sci. 2017, 18(4), 768; https://doi.org/10.3390/ijms18040768 - 5 Apr 2017
Cited by 12 | Viewed by 5698
Abstract
The ghrelin receptor (GhrR) is a widely investigated target in several diseases. However, the current knowledge of its role and distribution in the brain is limited. Recently, the small and non-peptidic compound (S)-6-(4-bromo-2-fluorophenoxy)-3-((1-isopropylpiperidin-3-yl)methyl)-2-methylpyrido[3,2-d]pyrimidin-4(3H)-one ((S)-9) has [...] Read more.
The ghrelin receptor (GhrR) is a widely investigated target in several diseases. However, the current knowledge of its role and distribution in the brain is limited. Recently, the small and non-peptidic compound (S)-6-(4-bromo-2-fluorophenoxy)-3-((1-isopropylpiperidin-3-yl)methyl)-2-methylpyrido[3,2-d]pyrimidin-4(3H)-one ((S)-9) has been described as a GhrR ligand with high binding affinity. Here, we describe the synthesis of fluorinated derivatives, the in vitro evaluation of their potency as partial agonists and selectivity at GhrRs, and their physicochemical properties. These results identified compounds (S)-9, (R)-9, and (S)-16 as suitable parent molecules for 18F-labeled positron emission tomography (PET) radiotracers to enable future investigation of GhrR in the brain. Full article
(This article belongs to the Special Issue Neurobiological Perspectives on Ghrelin)
Show Figures

Graphical abstract

18 pages, 2808 KiB  
Article
Delphinidin Reduces Glucose Uptake in Mice Jejunal Tissue and Human Intestinal Cells Lines through FFA1/GPR40
by Jorge Hidalgo 1, Stefanie Teuber 1, Francisco J. Morera 1, Camila Ojeda 1, Carlos A. Flores 2, María A. Hidalgo 1, Lucía Núñez 3,4, Carlos Villalobos 3,4 and Rafael A. Burgos 1,*
1 Institute of Pharmacology and Morphophysiology, Universidad Austral de Chile, 5110566 Valdivia, Chile
2 Centro de Estudios Científicos (CECs), Avenida Arturo Prat 514, 511046 Valdivia, Chile
3 Instituto de Biología y Genética Molecular (IBGM), Consejo Superior de Investigaciones Científicas (CSIC), 47003 Valladolid, Spain
4 Departamento de Bioquímica y Biología Molecular y Fisiología, Universidad de Valladolid, 47003 Valladolid, Spain
Int. J. Mol. Sci. 2017, 18(4), 750; https://doi.org/10.3390/ijms18040750 - 5 Apr 2017
Cited by 43 | Viewed by 6941
Abstract
Anthocyanins are pigments with antihyperglycemic properties, and they are potential candidates for developing functional foods for the therapy or prevention of Diabetes mellitus type 2 (DM2). The mechanism of these beneficial effects of anthocyanins are, however, hard to explain, given their very low [...] Read more.
Anthocyanins are pigments with antihyperglycemic properties, and they are potential candidates for developing functional foods for the therapy or prevention of Diabetes mellitus type 2 (DM2). The mechanism of these beneficial effects of anthocyanins are, however, hard to explain, given their very low bioavailability due to poor intestinal absorption. We propose that free fatty acid receptor 1 (FFA1, also named GPR40), is involved in an inhibitory effect of the anthocyanidin delphinidin over intestinal glucose absorption. We show the direct effects of delphinidin on the intestine using jejunum samples from RF/J mice, and the human intestinal cell lines HT-29, Caco-2, and NCM460. By the use of specific pharmacological antagonists, we determined that delphinidin inhibits glucose absorption in both mouse jejunum and a human enterocytic cell line in a FFA1-dependent manner. Delphinidin also affects the function of sodium-glucose cotransporter 1 (SGLT1). Intracellular signaling after FFA1 activation involved cAMP increase and cytosolic Ca2+ oscillations originated from intracellular Ca2+ stores and were followed by store-operated Ca2+ entry. Taken together, our results suggest a new GPR-40 mediated local mechanism of action for delphinidin over intestinal cells that may in part explain its antidiabetic effect. These findings are promising for the search for new prevention and pharmacological treatment strategies for DM2 management. Full article
(This article belongs to the Special Issue Anthocyanins)
Show Figures

Graphical abstract

10 pages, 8616 KiB  
Article
Exome Sequencing Identified a Novel FBN2 Mutation in a Chinese Family with Congenital Contractural Arachnodactyly
by Guoling You 1,†, Bailing Zu 2,3,†, Bo Wang 1, Zhigang Wang 4, Yunlan Xu 4,* and Qihua Fu 1,*
1 Department of Laboratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
2 Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200127, China
3 Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 200127, China
4 Department of Pediatric Orthopedics, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
These authors contributed equally to this work.
Int. J. Mol. Sci. 2017, 18(4), 626; https://doi.org/10.3390/ijms18040626 - 5 Apr 2017
Cited by 11 | Viewed by 7420
Abstract
Congenital contractural arachnodactyly (CCA) is an autosomal dominant disorder of connective tissue. CCA is characterized by arachnodactyly, camptodactyly, contrature of major joints, scoliosis, pectus deformities, and crumpled ears. The present study aimed to identify the genetic cause of a three-generation Chinese family with [...] Read more.
Congenital contractural arachnodactyly (CCA) is an autosomal dominant disorder of connective tissue. CCA is characterized by arachnodactyly, camptodactyly, contrature of major joints, scoliosis, pectus deformities, and crumpled ears. The present study aimed to identify the genetic cause of a three-generation Chinese family with CCA. We successfully identified a novel missense mutation p.G1145D in the fibrillin-2 (FBN2) gene as the pathogenic mutation by whole exome sequencing (WES). The p.G1145D mutation occurs in the 12th calcium-binding epidermal growth factor-like (cbEGF) domain. The p.G1145D mutation caused a hydrophobic to hydrophilic substitution, altering the amino acid property from neutral to acidic. Three-dimensional structural analysis showed that this mutation could alter the conformation of the residue side chain, thereby producing steric clashes with spatially adjacent residues, disrupting the formation of H bonds and causing folding destabilization. Therefore, this amino acid appears to play an important role in the structure and function of FBN2. Our results may also provide new insights into the cause and diagnosis of CCA and may have implications for genetic counseling and clinical management. Full article
(This article belongs to the Special Issue Human Single Nucleotide Polymorphisms and Disease Diagnostics)
Show Figures

Figure 1

13 pages, 1478 KiB  
Article
Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination
by Takao Itoi 1,*, Masahiro Sugimoto 2, Junko Umeda 1, Atsushi Sofuni 1, Takayoshi Tsuchiya 1, Shujiro Tsuji 1, Reina Tanaka 1, Ryosuke Tonozuka 1, Mitsuyoshi Honjo 1, Fuminori Moriyasu 1, Kazuhiko Kasuya 3, Yuichi Nagakawa 3, Yuta Abe 4, Kimihiro Takano 4, Shigeyuki Kawachi 4, Motohide Shimazu 4, Tomoyoshi Soga 2, Masaru Tomita 2 and Makoto Sunamura 4
1 Division of Gastroenterology and Hepatology, Tokyo Medical University, Shinjuku, Tokyo 160-0023, Japan
2 Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0052, Japan
3 Third Department of Surgery, Tokyo Medical University, Shinjuku, Tokyo 160-0023, Japan
4 Fourth Department of Surgery, Tokyo Medical University Hachioji Medical Center, Hachioji,Tokyo 193-0998, Japan
Int. J. Mol. Sci. 2017, 18(4), 767; https://doi.org/10.3390/ijms18040767 - 4 Apr 2017
Cited by 22 | Viewed by 5955
Abstract
This study evaluated the clinical use of serum metabolomics to discriminate malignant cancers including pancreatic cancer (PC) from malignant diseases, such as biliary tract cancer (BTC), intraductal papillary mucinous carcinoma (IPMC), and various benign pancreaticobiliary diseases. Capillary electrophoresismass spectrometry was used to analyze [...] Read more.
This study evaluated the clinical use of serum metabolomics to discriminate malignant cancers including pancreatic cancer (PC) from malignant diseases, such as biliary tract cancer (BTC), intraductal papillary mucinous carcinoma (IPMC), and various benign pancreaticobiliary diseases. Capillary electrophoresismass spectrometry was used to analyze charged metabolites. We repeatedly analyzed serum samples (n = 41) of different storage durations to identify metabolites showing high quantitative reproducibility, and subsequently analyzed all samples (n = 140). Overall, 189 metabolites were quantified and 66 metabolites had a 20% coefficient of variation and, of these, 24 metabolites showed significant differences among control, benign, and malignant groups (p < 0.05; Steel–Dwass test). Four multiple logistic regression models (MLR) were developed and one MLR model clearly discriminated all disease patients from healthy controls with an area under receiver operating characteristic curve (AUC) of 0.970 (95% confidential interval (CI), 0.946–0.994, p < 0.0001). Another model to discriminate PC from BTC and IPMC yielded AUC = 0.831 (95% CI, 0.650–1.01, p = 0.0020) with higher accuracy compared with tumor markers including carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), pancreatic cancer-associated antigen (DUPAN2) and s-pancreas-1 antigen (SPAN1). Changes in metabolomic profiles might be used to screen for malignant cancers as well as to differentiate between PC and other malignant diseases. Full article
(This article belongs to the Special Issue Pancreatic Disorders)
Show Figures

Graphical abstract

18 pages, 4889 KiB  
Article
Visualization of Alternative Functional Configurations of Influenza Virus Hemagglutinin Facilitates Rapid Selection of Complementing Vaccines in Emergency Situations
by Ashraf Metwally 1 and Ausama Yousif 2,*
1 Veterinary Virologist and Consultant, Cairo 11441, Egypt
2 Virology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
Int. J. Mol. Sci. 2017, 18(4), 766; https://doi.org/10.3390/ijms18040766 - 4 Apr 2017
Cited by 1 | Viewed by 5545
Abstract
Successful immunization against avian influenza virus (AIV) requires eliciting an adequate polyclonal response to AIV hemagglutinin (HA) subunit 1 (HA1) epitopes. Outbreaks of highly-pathogenic (HP) AIV subtype H5N1 can occur in vaccinated flocks in many endemic areas. Protection against emerging AIV is partly [...] Read more.
Successful immunization against avian influenza virus (AIV) requires eliciting an adequate polyclonal response to AIV hemagglutinin (HA) subunit 1 (HA1) epitopes. Outbreaks of highly-pathogenic (HP) AIV subtype H5N1 can occur in vaccinated flocks in many endemic areas. Protection against emerging AIV is partly hindered by the limitations of vaccine production and transport, the use of leaky vaccines, and the use of multiple, and often antigenically-diverse, vaccines. It was hypothesized that the majority of alternative functional configurations (AFC) within the AIV HA1 can be represented by the pool of vaccine seed viruses currently in production because only a finite number of AFC are possible within each substructure of the molecule. Therefore, combinations of commercial vaccines containing complementing structural units (CSU) to each HA1 substructure can elicit responses to the totality of a given emerging AIV HA1 substructure isoforms. Analysis of homology-based 3D models of vaccine seed and emerging viruses facilitated the definition of HA1 AFC isoforms. CSU-based plots were used to predict which commercial vaccine combinations could have been used to cover nine selected AFC isoforms on recent Egyptian HP AIV H5N1 outbreak viruses. It is projected that expansion of the vaccine HA1 3D model database will improve international emergency responses to AIV. Full article
Show Figures

Figure 1

22 pages, 1216 KiB  
Review
Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression
by Abdullah Mayati 1, Amélie Moreau 2, Marc Le Vée 1, Bruno Stieger 3, Claire Denizot 2, Yannick Parmentier 2 and Olivier Fardel 1,4,*
1 Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 2 Avenue du Pr Léon Bernard, 35043 Rennes, France
2 Centre de Pharmacocinétique, Technologie Servier, 25–27 Rue Eugène Vignat, 45000 Orléans, France
3 Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091 Zurich, Switzerland
4 Pôle Biologie, Centre Hospitalier Universitaire, 2 rue Henri le Guilloux, 35033 Rennes, France
Int. J. Mol. Sci. 2017, 18(4), 764; https://doi.org/10.3390/ijms18040764 - 4 Apr 2017
Cited by 39 | Viewed by 7003
Abstract
Drug transporters are now recognized as major actors in pharmacokinetics, involved notably in drug–drug interactions and drug adverse effects. Factors that govern their activity, localization and expression are therefore important to consider. In the present review, the implications of protein kinases C (PKCs) [...] Read more.
Drug transporters are now recognized as major actors in pharmacokinetics, involved notably in drug–drug interactions and drug adverse effects. Factors that govern their activity, localization and expression are therefore important to consider. In the present review, the implications of protein kinases C (PKCs) in transporter regulations are summarized and discussed. Both solute carrier (SLC) and ATP-binding cassette (ABC) drug transporters can be regulated by PKCs-related signaling pathways. PKCs thus target activity, membrane localization and/or expression level of major influx and efflux drug transporters, in various normal and pathological types of cells and tissues, often in a PKC isoform-specific manner. PKCs are notably implicated in membrane insertion of bile acid transporters in liver and, in this way, are thought to contribute to cholestatic or choleretic effects of endogenous compounds or drugs. The exact clinical relevance of PKCs-related regulation of drug transporters in terms of drug resistance, pharmacokinetics, drug–drug interactions and drug toxicity remains however to be precisely determined. This issue is likely important to consider in the context of the development of new drugs targeting PKCs-mediated signaling pathways, for treating notably cancers, diabetes or psychiatric disorders. Full article
(This article belongs to the Special Issue Kinase Signal Transduction 2017)
Show Figures

Figure 1

10 pages, 1433 KiB  
Article
A New Chemical Pathway Yielding A-Type Vitisins in Red Wines
by Paula Araújo, Ana Fernandes, Victor De Freitas and Joana Oliveira *
Laboratório Associado para a Química Verde, Departamento de Química e Bioquímica, Faculdade de Ciências da Universidade do Porto, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal
Int. J. Mol. Sci. 2017, 18(4), 762; https://doi.org/10.3390/ijms18040762 - 4 Apr 2017
Cited by 14 | Viewed by 4869
Abstract
A new chemical pathway yielding A-type vitisins in red wines is proposed herein from the reaction between anthocyanins and oxaloacetic acid (OAA). This new chemical path is thought to occur in the first stages of the wine production even during the fermentation process. [...] Read more.
A new chemical pathway yielding A-type vitisins in red wines is proposed herein from the reaction between anthocyanins and oxaloacetic acid (OAA). This new chemical path is thought to occur in the first stages of the wine production even during the fermentation process. This is due to the revealed high reactivity of OAA with anthocyanins compared with the already known precursor (pyruvic acid, PA). In model solutions at wine pH (3.5), when malvidin-3-O-glucoside (mv-3-glc) is in contact with OAA and PA a decrease in the OAA concentration is observed along with the formation of A-type vitisin. Moreover, part of the OAA is also chemically converted into PA in model solutions. The reaction yields were also determined for OAA and PA using different mv-3-glc:organic acid molar ratios (1:0.5, 1:1, 1:5, 1:10; 1:50, and 1:100) and these values were always higher for OAA when compared to PA, even at the lowest molar ratio (1:0.5). The reaction yields were higher at pH 2.6 in comparison to pH 1.5 and 3.5, being less affected at pH 3.5 for OAA. These results support the idea that OAA can be at the origin of A-type vitisins in the first stages of wine production and PA in the subsequent ageing process. Full article
(This article belongs to the Special Issue Anthocyanins)
Show Figures

Figure 1

10 pages, 3631 KiB  
Article
Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation
by David Voigt 1, Uta Scheidt 1, Tobias Derfuss 2, Wolfgang Brück 1 and Andreas Junker 3,*
1 Institute of Neuropathology, University Medical Center, Robert-Koch-Straße 40, Göttingen 37075, Germany
2 Neurologic Clinic and Policlinic, University Hospital Basel, Basel 4031, Switzerland
3 Institute of Neuropathology, University Hospital Essen, Hufelandstr. 55, Essen 45122, Germany
Int. J. Mol. Sci. 2017, 18(4), 760; https://doi.org/10.3390/ijms18040760 - 4 Apr 2017
Cited by 32 | Viewed by 6031
Abstract
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, characterized by demyelination and axonal damage as well as neuronal degeneration. Since oxygen-derived free radicals are an important factor leading to tissue damage in inflammatory multiple sclerosis (MS) lesions, research on [...] Read more.
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, characterized by demyelination and axonal damage as well as neuronal degeneration. Since oxygen-derived free radicals are an important factor leading to tissue damage in inflammatory multiple sclerosis (MS) lesions, research on antioxidative systems is essential to identify endogenous factors which can possibly counteract oxidative damage. As an important scavenging enzyme family, peroxiredoxins (PRDXs) play a crucial role in preventing oxidative damage; however little is known about their expression and function in MS lesions. In the present study we examined the expression of PRDX2 in white matter lesions of MS patients with long-standing, chronic disease. PRDX2 expression was investigated by immunohistochemistry in the context of oxidative stress and inflammation (determined by microglia/macrophage and T cell infiltration) in ten MS autopsy cases as well as seven control autopsy cases. PRDX2 was found to be upregulated in white matter MS lesions mainly in astrocytes, and its expression level was positively correlated with the degree of inflammation and oxidative stress. Our data suggest that PRDX2 expression contributes to the resistance of astrocytes against oxidative damage. Full article
(This article belongs to the Special Issue Advances in Multiple Sclerosis 2016)
Show Figures

Figure 1